Page 2 - Dr Reddys Laboratories Ltd News
Dr Reddy's Laboratories Q1 result: Net profit dips 0.90%, revenue up 13.88%
DRL's growth was primarily driven by the robust performance of the global generics business, particularly in North America and India
 "Dr Reddy's Laboratories Q1 result: Net profit dips 0.90%, revenue up 13.88%")
Updated On : 27 Jul 2024 | 6:08 PM IST
Dr Reddy's Labs Q1 Preview: Market share loss in products to drag profits
Indian drugmaker, Dr Reddy's Laboratories is all set to deliver its financial performance for the first quarter of financial year 2024-25 (Q1FY25) on Saturday, July 27, 2024
Updated On : 25 Jul 2024 | 2:14 PM IST
Pharma shares shine; Dr Reddy's, FDC, Glenmark, Suven trade at record highs
Shares of Wockhardt hit a multi-year high of Rs 943.20, zooming 65 per cent in past nine trading days.
 "Pharma shares shine; Dr Reddy's, FDC, Glenmark, Suven trade at record highs")
Updated On : 03 Jul 2024 | 2:57 PM IST
Earnings boost for Dr Reddy's Lab post consumer healthcare acquisition
In India, DRL has an OTC portfolio in the hydration, cough-cold-allergy, and skin care categories
Updated On : 27 Jun 2024 | 9:57 PM IST
Dr Reddy's shares zoom post Nicotinell acquisition; brokerages unimpressed
On Thursday, shares of the Dr Reddy's Laboratories zoomed up to 2.7 per cent at Rs 6,235.90 a piece on the BSE. The stock rose after the company on Wednesday acquired OTC brand Nicotinell
 "Dr Reddy's shares zoom post Nicotinell acquisition; brokerages unimpressed")
Updated On : 27 Jun 2024 | 11:03 AM IST
